Affiliations 

  • 1 Department of Medicine, College of Medicine, King Saudi bin Abdulaziz University for Health Sciences, PO Box 84252, 11671, Riyadh, Kingdom of Saudi Arabia. almoamary@yahoo.com
  • 2 General Medicines, GSK, Singapore, Singapore
  • 3 Microbiology Department, College of Medicine, Kuwait University, Kuwait City, Kuwait
  • 4 Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
  • 5 UK St. Claire, Morehead, KY, USA
  • 6 GSK, Ciudad de Panamá, Panamá
  • 7 GSK, Mumbai, India
  • 8 Adelphi Real World, Bollington, UK
Adv Ther, 2025 Feb 06.
PMID: 39912987 DOI: 10.1007/s12325-025-03105-x

Abstract

INTRODUCTION: Patient adherence to regular controller medication is critical for improving clinical outcomes in asthma, which is consistently associated with underlying pathophysiological inflammation. This survey aimed to identify types of treatment nonadherence and associated factors, including patient characteristics that predict poor adherence, in patients with asthma.

METHODS: This cross-sectional online survey involved patients with asthma and physicians managing such patients from Southeast Asia (Indonesia, Malaysia, Philippines, Thailand and Vietnam) and the Middle East (Saudi Arabia and United Arab Emirates) included in the Asthma Patients' and Physicians' Perspectives on the Burden and Management of Asthma (APPaRENT) 3 study. Patients and physicians shared their attitudes and beliefs regarding treatment and adherence in asthma management.

RESULTS: Most patients (82%, 1108/1354) reported having ever received treatment with daily controller inhalers, whereas 38% used inhaled relievers at least once daily for symptomatic relief. Among those prescribed maintenance and reliever therapy, 93% were prescribed a separate inhaled reliever, with significant variation by country (P 

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.